Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

June 17, 2019June 17, 2019

‘Multimorbidity’ More Likely in Axial Spondyloarthropathy, Linked to Worse Outcomes, Irish Study Finds

News

People with axial spondyloarthropathy are more prone to develop additional disorders — called “multimorbidity” — which is associated with worse disease outcomes, according to a recent Irish study. The ... Read more

June 3, 2019June 3, 2019

Physical Function in AS Not Affected by Other Comorbidities, Study Suggests

News

People with ankylosing spondylitis and psoriatic arthritis both are prone to developing additional diseases (comorbidities). However, only in patients with psoriatic arthritis do comorbidities seem to have a negative ... Read more

April 4, 2019April 4, 2019

Simponi Aria Shows Signs of Efficacy in Patients with Active Ankylosing Spondylitis

News

Treatment with Simponi Aria (golimumab) for one year reduced the signs and symptoms of ankylosing spondylitis (AS) among adult patients with active disease, Phase 3 trial data show. The study, ... Read more

February 27, 2019March 27, 2019

Ankylosing Spondylitis Patients Have Higher Risk of Blood Clots, Study Suggests

News

Ankylosing spondylitis (AS) patients have a more than 50% increased risk of developing blood vessel clots, according to a population-based Canadian study. “Clinicians should have an increased awareness of ... Read more

February 11, 2019February 11, 2019

Risk for Dementia Higher in Ankylosing Spondylitis Patients, Study Suggests

News

The risk for developing overall dementia and Alzheimer’s disease dementia is higher in patients with ankylosing spondylitis (AS), according to a nationwide study in South Korea. The study, “Relationship ... Read more

January 9, 2019January 9, 2019

Risk of Atrial Fibrillation Increases in Certain Ankylosing Spondylitis Patients, Study Finds

News

Ankylosing spondylitis (AS) patients younger than 40 and those treated with tumor necrosis factor inhibitors (TNFi) are at a higher risk of developing atrial fibrillation, a heart condition that ... Read more

June 6, 2018June 8, 2018

Hypertension, Depression More Common in Patients Than Others of Same Age and Sex, Study Reports

Just Published, News

Ankylosing spondylitis patients carry a significantly higher burden for several comorbidities — other diseases — than are found in people without this inflammatory disorder of the same age and ... Read more

May 30, 2018May 30, 2018

Humira of Benefit Over Long Term to Nonradiographic Axial Spondyloarthritis Patients, Study Reports

News

Long-term treatment with Abbvie‘s adalimumab, sold as Humira, led to sustained clinical remission accompanied by better physical abilities in patients with nonradiographic axial spondyloarthritis (nr-axSpA). “Clinical and MRI remission ... Read more

April 23, 2018April 23, 2018

Increase in Early Spondyloarthritis Activity Linked to Decline in Physical Quality of Life, Study Shows

News

An increase in disease activity during the early stages of axial spondyloarthritis (axSpA) is linked to a decline in physical health-related quality of life in patients over time, according ... Read more

March 7, 2018March 7, 2018

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News

Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were ... Read more

Pin It on Pinterest